"The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach./"...
- Patient Information:
Details with Side Effects
Advise patients to report severe headaches, nausea, vomiting or new onset visual disturbances [see WARNINGS AND PRECAUTIONS].
Impaired Neurosurgical Wound Healing
Advise patients to report any evidence of wound dehiscence, fever or cerebrospinal fluid leak [see WARNINGS AND PRECAUTIONS].
Advise nursing mothers to discontinue nursing after GLIADEL WAFER implantation [see Use In Specific Populations].
Last reviewed on RxList: 9/4/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Gliadel Information
Gliadel - User Reviews
Gliadel User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.